Medindia LOGIN REGISTER
Medindia
Brachytherapy for Prostate Cancer - Doses, Side Effects, Precautions

Brachytherapy for Prostate Cancer - References


References:

  1. Current Status of Brachytherapy for Prostate Cancer - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502731/)
  2. Brachytherapy - (https://www.ncbi.nlm.nih.gov/books/NBK562190/)
  3. Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635047/)
  4. Brachytherapy in the therapy of prostate cancer – an interesting choice - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934024/)
  5. Anaesthesia for brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/18660663/)
  6. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials - (https://pubmed.ncbi.nlm.nih.gov/21763066/)
  7. Iodine-125 and Palladium-103 Low Dose Rate Brachytherapy Seeds Used for Localization of Non-Palpable Lesions - (https://www.nrc.gov/materials/miau/med-use-toolkit/seed-localization.html)
  8. Brachytherapy as a treatment option for prostate cancer: overview and nursing considerations - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317044/)
  9. Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349732/)
  10. Radiotherapy: Basic Concepts and Recent Advances - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920949/)
  11. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/28109634/)
  12. Brachytherapy in the treatment of cervical cancer: a review- (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045176/)
  13. Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430680/)
  14. High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789612/)
  15. High dose rate brachytherapy as monotherapy for localised prostate cancer - (https://pubmed.ncbi.nlm.nih.gov/29074079/)
  16. HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis - (https://pubmed.ncbi.nlm.nih.gov/33461894/)
  17. Quality of life outcomes after brachytherapy for early stage prostate cancer - (https://pubmed.ncbi.nlm.nih.gov/10687991/)
  18. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience - (https://pubmed.ncbi.nlm.nih.gov/19589580/)
  19. Management of sexual dysfunction after prostate brachytherapy - (https://pubmed.ncbi.nlm.nih.gov/12599931/)
  20. Less restrictive patient-specific radiation-safety precautions can be safely prescribed after permanent seed implantation - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819139/)
  21. Radiation Therapy for Prostate Cancer - (https://www.cancer.org/cancer/prostate-cancer/treating/radiation-therapy.html)
Author: Sneha Bhatt

Editor: Dr. Krishanga

Technical: Lingaraj
Advertisement